Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Barbie

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2008
Highly parallel identification of essential genes in cancer cellsBiao Luo, Hiu Wing Cheung, Aravind Subramanian, et al.
Oncoimmunology|April 14, 2017
Tumor SQSTM1 (p62) expression and T cells in colorectal cancerKeisuke Kosumi, Yohei Masugi, Juhong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Use of <i>Ex</i> <i>Vivo</i> Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for <i>HER2</i> Mutant Non-Small Cell Lung CancerElena Ivanova, Mari Kuraguchi, Man Xu, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
Cancer Discovery|April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung CancerDennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
Developmental Cell|August 27, 2025
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancerDeli Hong, Ying Lyu, Richa Nayak, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2014
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitorsLi Tan, Jun Wang, Junko Tanizaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2008
Highly parallel identification of essential genes in cancer cellsBiao Luo, Hiu Wing Cheung, Aravind Subramanian, et al.
Oncoimmunology|April 14, 2017
Tumor SQSTM1 (p62) expression and T cells in colorectal cancerKeisuke Kosumi, Yohei Masugi, Juhong Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2020
Use of <i>Ex</i> <i>Vivo</i> Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for <i>HER2</i> Mutant Non-Small Cell Lung CancerElena Ivanova, Mari Kuraguchi, Man Xu, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
Cancer Discovery|April 15, 2017
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung CancerDennis O Adeegbe, Yan Liu, Patrick H Lizotte, et al.
Developmental Cell|August 27, 2025
Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancerDeli Hong, Ying Lyu, Richa Nayak, et al.
Cancer Discovery|May 7, 2020
Inactivation of <i>Fbxw7</i> Impairs dsRNA Sensing and Confers Resistance to PD-1 BlockadeCécile Gstalder, David Liu, Diana Miao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Assessing Therapeutic Efficacy of MEK Inhibition in a KRAS<sup>G12C</sup>-Driven Mouse Model of Lung CancerShuai Li, Shengwu Liu, Jiehui Deng, et al.
Pageof 12